Mitotic arrest with nocodazole induces selective changes in the level of O-linked N-acetylglucosamine and accumulation of incompletely processed N-glycans on proteins from HT29 cells
- PMID: 9079710
- DOI: 10.1074/jbc.272.13.8752
Mitotic arrest with nocodazole induces selective changes in the level of O-linked N-acetylglucosamine and accumulation of incompletely processed N-glycans on proteins from HT29 cells
Abstract
O-Linked N-acetylglucosamine (O-GlcNAc) is a ubiquitous and abundant protein modification found on nuclear and cytoplasmic proteins. Several lines of evidence suggest that it is a highly dynamic modification and that the levels of this sugar on proteins may be regulated. Previous workers (Chou, C. F., and Omary, M. B. (1993) J. Biol. Chem. 268, 4465-4472) have shown that mitotic arrest with microtubule-destabilizing agents such as nocodazole causes an increase in the O-GlcNAc levels on keratins in the human colon cancer cell line HT29. We have sought to determine whether this increase in glycosylation is a general (i.e. occurring on many proteins) or a limited (i.e. occurring only on the keratins) process. A general increase would suggest that the microtubule-destabilizing agents were somehow affecting the enzymes responsible for addition and/or removal of O-GlcNAc. Our results suggest that the changes in O-GlcNAc induced by nocodazole are selective for the keratins. The levels of O-GlcNAc on other proteins, including the nuclear pore protein p62 and the transcription factor Sp1, are not significantly affected by this treatment. In agreement with these findings, nocodazole treatment caused no change in the activity of the enzymes responsible for addition or removal of O-GlcNAc as determined by direct in vitro assay. Interestingly, nocodazole treatment did cause a dramatic increase in modification of N-glycans with terminal GlcNAc residues on numerous proteins. Potential mechanisms for this and the change in glycosylation of the keratins are discussed.
Similar articles
-
Mitotic arrest with anti-microtubule agents or okadaic acid is associated with increased glycoprotein terminal GlcNAc's.J Cell Sci. 1994 Jul;107 ( Pt 7):1833-43. doi: 10.1242/jcs.107.7.1833. J Cell Sci. 1994. PMID: 7527049
-
Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.J Biol Chem. 1998 Feb 6;273(6):3611-7. doi: 10.1074/jbc.273.6.3611. J Biol Chem. 1998. PMID: 9452489
-
Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration.Biochem J. 2000 Aug 15;350 Pt 1(Pt 1):109-14. Biochem J. 2000. PMID: 10926833 Free PMC article.
-
Glycan-dependent signaling: O-linked N-acetylglucosamine.FASEB J. 2001 Sep;15(11):1865-76. doi: 10.1096/fj.01-0094rev. FASEB J. 2001. PMID: 11532966 Review.
-
Glycosylation of the nuclear pore.Traffic. 2014 Apr;15(4):347-61. doi: 10.1111/tra.12150. Epub 2014 Feb 13. Traffic. 2014. PMID: 24423194 Free PMC article. Review.
Cited by
-
Gigaxonin glycosylation regulates intermediate filament turnover and may impact giant axonal neuropathy etiology or treatment.JCI Insight. 2019 Nov 26;5(1):e127751. doi: 10.1172/jci.insight.127751. Print 2020 Jan 16. JCI Insight. 2019. PMID: 31944090 Free PMC article.
-
O-GlcNAcylation: A New Cancer Hallmark?Front Endocrinol (Lausanne). 2013 Aug 12;4:99. doi: 10.3389/fendo.2013.00099. eCollection 2013. Front Endocrinol (Lausanne). 2013. PMID: 23964270 Free PMC article.
-
Vertebrate protein glycosylation: diversity, synthesis and function.Nat Rev Mol Cell Biol. 2012 Jun 22;13(7):448-62. doi: 10.1038/nrm3383. Nat Rev Mol Cell Biol. 2012. PMID: 22722607 Free PMC article. Review.
-
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.Am J Physiol Heart Circ Physiol. 2012 May 15;302(10):H1905-18. doi: 10.1152/ajpheart.00445.2011. Epub 2012 Jan 27. Am J Physiol Heart Circ Physiol. 2012. PMID: 22287582 Free PMC article. Review.
-
O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.J Bioenerg Biomembr. 2018 Jun;50(3):155-173. doi: 10.1007/s10863-018-9751-2. Epub 2018 Mar 29. J Bioenerg Biomembr. 2018. PMID: 29594839 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources